002826.SZ

Tibet AIM Pharm. Inc. [002826.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

002826.SZ Stock Summary

Top 10 Correlated ETFs

002826.SZ


Top 10 Correlated Stocks

002826.SZ


In the News

002826.SZ Financial details

Company Rating
Buy
Market Cap
1.65B
Income
46.78M
Revenue
803.27M
Book val./share
3.95
Cash/share
1.56
Dividend
0.1
Dividend %
0.86%
Employees
447
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
49.29
Forward P/E
-
PEG
51.64
P/S
2.76
P/B
3.06
P/C
5.54
P/FCF
29.43
Quick Ratio
2.15
Current Ratio
2.4
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
0.24
EPS next Y
-
EPS next Q
-
EPS this Y
4.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.09%
Revenue last 5Y
11.88%
Revenue Q/Q
-21.04%
EPS Q/Q
73.65%
-
-
-
-
SMA20
12.5%
SMA50
-25%
SMA100
-18.18%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.07%
Gross Margin
47%
Oper. Margin
7%
Profit Margin
6%
Payout
44%
Shs Outstand
190.68M
Shs Float
163.58M
-
-
-
-
Target Price
-
52W Range
5.57-13.28
52W High
-33.46%
52W Low
+73%
RSI
50
Rel Volume
1.14
Avg Volume
6.04M
Volume
6.88M
Perf Week
-3.67%
Perf Month
27.21%
Perf Quarter
-
Perf Half Y
-24.65%
-
-
-
-
Beta
0.295
-
-
Volatility
0.24%, 0.43%
Prev Close
3.1%
Price
8.65
Change
6.13%

002826.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.582.963.233.814.49
Net income per share
0.130.20.220.220.23
Operating cash flow per share
0.070.320.540.580.36
Free cash flow per share
-0.29-0.60.340.440.34
Cash per share
1.261.021.10.961.68
Book value per share
3.263.493.683.773.91
Tangible book value per share
2.983.23.43.43.58
Share holders equity per share
3.263.493.683.773.91
Interest debt per share
0.220.390.220.040.27
Market cap
1.89B1.89B1.82B2.08B1.94B
Enterprise value
1.69B1.8B1.66B1.91B1.67B
P/E ratio
74.9350.5544.3649.0344.02
Price to sales ratio
3.873.413.032.872.27
POCF ratio
142.1431.8717.9219.0228.38
PFCF ratio
-34.79-16.9628.824.729.78
P/B Ratio
3.062.892.652.92.61
PTB ratio
3.062.892.652.92.61
EV to sales
3.473.252.752.631.95
Enterprise value over EBITDA
41.829.9624.5327.0219.97
EV to operating cash flow
127.2230.3516.2917.4124.42
EV to free cash flow
-31.13-16.1526.1822.6125.62
Earnings yield
0.010.020.020.020.02
Free cash flow yield
-0.03-0.060.030.040.03
Debt to equity
0.060.110.060.010.07
Debt to assets
0.050.080.040.010.05
Net debt to EBITDA
-4.9-1.5-2.45-2.5-3.24
Current ratio
3.372.222.063.652.2
Interest coverage
19.4617.6126.6757.6968.75
Income quality
0.531.592.482.521.48
Dividend Yield
0.0100.010.010.01
Payout ratio
0.510.230.230.380.45
Sales general and administrative to revenue
0.030.030.030.040.03
Research and developement to revenue
0.030.010.010.020.02
Intangibles to total assets
0.070.070.060.090.07
Capex to operating cash flow
-5.09-2.88-0.38-0.23-0.05
Capex to revenue
-0.14-0.31-0.06-0.030
Capex to depreciation
-7.15-15.62-2.3-1.06-0.14
Stock based compensation to revenue
00000
Graham number
3.123.974.274.354.51
ROIC
0.040.050.050.060.06
Return on tangible assets
0.040.050.050.060.05
Graham Net
1.370.810.871.061.22
Working capital
326.56M220.26M231.98M262.83M313.1M
Tangible asset value
564.54M597.56M635.87M646.39M682.42M
Net current asset value
324.68M217.33M229.31M257.81M306.8M
Invested capital
0.060.110.060.010.07
Average receivables
189.03M184.44M198.69M182.9M174.96M
Average payables
9.69M19.09M33.08M28.2M72.11M
Average inventory
31.42M29.13M25.15M27.15M39.58M
Days sales outstanding
145.95114.42135.6471.3788.64
Days payables outstanding
12.3226.5337.0713.596.47
Days of inventory on hand
31.4529.1319.5826.3834.6
Receivables turnover
2.53.192.695.114.12
Payables turnover
29.6413.769.8527.033.78
Inventory turnover
11.6112.5318.6413.8310.55
ROE
0.040.060.060.060.06
Capex per share
-0.36-0.91-0.21-0.13-0.02

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.971.410.820.980.85
Net income per share
0.040.120.040.030.05
Operating cash flow per share
0.040.120.040.220
Free cash flow per share
0.040.120.040.220
Cash per share
1.411.711.691.711.56
Book value per share
3.383.963.63.653.95
Tangible book value per share
3.073.633.313.363.65
Share holders equity per share
3.383.963.63.653.95
Interest debt per share
0.240.270.240.240.05
Market cap
2.04B1.92B2.25B2.3B2.2B
Enterprise value
1.89B1.65B2.05B2.15B1.98B
P/E ratio
55.0820.9467.25100.6655.99
Price to sales ratio
9.917.2413.1211.2313.57
POCF ratio
220.383.7626949.7951.9K
PFCF ratio
227.4887.45276.2650.14-3.89K
P/B Ratio
2.842.572.993.022.91
PTB ratio
2.842.572.993.022.91
EV to sales
9.186.2111.9410.4712.23
Enterprise value over EBITDA
156.3751.11220.12358.11147.66
EV to operating cash flow
204.0371.91244.8146.446.76K
EV to free cash flow
210.6875.08251.4146.73-3.51K
Earnings yield
00.01000
Free cash flow yield
00.0100.020
Debt to equity
0.070.070.070.070.01
Debt to assets
0.050.050.050.050.01
Net debt to EBITDA
-12.47-8.42-21.75-26.14-16.23
Current ratio
2.452.22.332.252.4
Interest coverage
42.0251.2126.0215.7954.62
Income quality
1118.090
Dividend Yield
00000.01
Payout ratio
1.070.020.060.081.96
Sales general and administrative to revenue
0.11-0.020.060.020.17
Research and developement to revenue
00.0400.030.03
Intangibles to total assets
0.070.070.070.060.06
Capex to operating cash flow
-0.03-0.04-0.03-0.01-14.33
Capex to revenue
00000
Capex to depreciation
-0.05-0.16-0.04-0.050.05
Stock based compensation to revenue
00000
Graham number
1.823.291.81.52.14
ROIC
0.010.030.010.010.01
Return on tangible assets
0.010.020.010.010.01
Graham Net
1.041.231.211.131.18
Working capital
281.62M313.1M330.42M306.34M303.56M
Tangible asset value
653.96M682.42M692.3M703.21M695.71M
Net current asset value
277M306.8M321.3M297.43M294.86M
Invested capital
0.070.070.070.070.01
Average receivables
141.34M173.34M194.86M163.02M155.85M
Average payables
54.81M95.91M121.75M123.88M140.06M
Average inventory
35.74M39.1M44.76M47.47M52.86M
Days sales outstanding
60.5570.6795.3763.3893.04
Days payables outstanding
51.6576.28109.83106.19194.84
Days of inventory on hand
26.0227.3641.4441.2471.64
Receivables turnover
1.491.270.941.420.97
Payables turnover
1.741.180.820.850.46
Inventory turnover
3.463.292.172.181.26
ROE
0.010.030.010.010.01
Capex per share
0-0.01000

002826.SZ Frequently Asked Questions

What is Tibet AIM Pharm. Inc. stock symbol ?

Tibet AIM Pharm. Inc. is a CN stock and trading under the symbol 002826.SZ

What is Tibet AIM Pharm. Inc. stock quote today ?

Tibet AIM Pharm. Inc. stock price is $8.65 today.

Is Tibet AIM Pharm. Inc. stock public?

Yes, Tibet AIM Pharm. Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap